390 related articles for article (PubMed ID: 12649375)
1. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
3. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
[TBL] [Abstract][Full Text] [Related]
4. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
[TBL] [Abstract][Full Text] [Related]
5. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA
J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
[TBL] [Abstract][Full Text] [Related]
7. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
[TBL] [Abstract][Full Text] [Related]
8. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of the COX-2 inhibitor DFU, including a novel glutathione adduct rearomatization.
Yergey JA; Trimble LA; Silva J; Chauret N; Li C; Therien M; Grimm E; Nicoll-Griffith DA
Drug Metab Dispos; 2001 May; 29(5):638-44. PubMed ID: 11302928
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
Zoja C; Benigni A; Noris M; Corna D; Casiraghi F; Pagnoncelli M; Rottoli D; Abbate M; Remuzzi G
Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
[TBL] [Abstract][Full Text] [Related]
11. Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation.
Fornai M; Blandizzi C; Antonioli L; Colucci R; Bernardini N; Segnani C; De Ponti F; Del Tacca M
J Pharmacol Exp Ther; 2006 Jun; 317(3):938-45. PubMed ID: 16474005
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
[TBL] [Abstract][Full Text] [Related]
13. Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats--DFU and piroxicam study.
Burdan F
Toxicology; 2005 Jul; 211(1-2):12-25. PubMed ID: 15863244
[TBL] [Abstract][Full Text] [Related]
14. Different actions of the cyclooxygenase 2 selective inhibitor flosulide in rats with passive Heymann nephritis.
Heise G; Grabensee B; Schrör K; Heering P
Nephron; 1998 Oct; 80(2):220-6. PubMed ID: 9736824
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
Egan KM; Wang M; Fries S; Lucitt MB; Zukas AM; Puré E; Lawson JA; FitzGerald GA
Circulation; 2005 Jan; 111(3):334-42. PubMed ID: 15655126
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cyclooxygenase isoenzymes, nitric oxide, and afferent neurons in gastric mucosal defense in rats.
Ehrlich K; Sicking C; Respondek M; Peskar BM
J Pharmacol Exp Ther; 2004 Jan; 308(1):277-83. PubMed ID: 14569068
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of COX pathway in experimental myocardial infarction.
Saito T; Rodger IW; Hu F; Robinson R; Huynh T; Giaid A
J Mol Cell Cardiol; 2004 Jul; 37(1):71-7. PubMed ID: 15242737
[TBL] [Abstract][Full Text] [Related]
19. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
[TBL] [Abstract][Full Text] [Related]
20. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
